Palmitate oxidation in rat hepatocytes is inhibited by foetal calf serum

Area of Science:

• Biochemistry
• Mammalian Metabolism
• Fatty Acid Metabolism

Background:

• Fatty acid oxidation is minimal in mammals prior to birth.
• Understanding the regulation of fatty acid metabolism during fetal development is crucial.

Purpose of the Study:

• To investigate the effect of fetal calf serum (FCS) on fatty acid oxidation and synthesis in mammals.
• To identify the mechanism by which FCS influences fatty acid metabolism.

Main Methods:

• Comparing the oxidation rates of palmitate, laurate, and octanoate in the presence of FCS and newborn calf serum.
• Utilizing dialysis and ultra-filtration to determine the molecular weight of the active component in FCS.
• Assessing fatty acid synthesis from acetate.

Main Results:

• Fetal calf serum (FCS) significantly inhibits palmitate oxidation, while serum from newborn calves has minimal effect.
• FCS enhances fatty acid synthesis from acetate.
• The inhibitory effect of FCS on fatty acid oxidation appears to be mediated by the regulation of carnitine palmitoyltransferase I (CPT I) activity.
• The active component in FCS has a molecular weight less than 3 kDa.

Conclusions:

• Fetal calf serum (FCS) plays a role in regulating fatty acid metabolism during fetal development.
• CPT I activity is a key target for FCS-mediated inhibition of fatty acid oxidation.
• The findings suggest a specific molecular factor in FCS (<3 kDa) influences fetal fatty acid metabolism.